Newsletter Subject

Latest Health News and Whats New on Medindia

From

medindia.net

Email Address

newsletter@medindia.net

Sent On

Sat, Apr 21, 2018 05:27 AM

Email Preheader Text

--b2_0aad299ca46bd71cf65620bd7ab8c87c Content-Type: text/html; charset=UTF-8 Content-Transfer-Encodi

--b2_0aad299ca46bd71cf65620bd7ab8c87c Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable [3D"medindia"](3D"=) - 3D= - 3D" - [3D""](3D") - [3D""](3D") - [3D""](3D") Latest Health = News and What's New on Medindia [[3D"Therapeutic] Article Therapeutic Drug Monito= ring Therapeutic drug monitoring is measuring drug concentrations at spec= ific intervals in a patient's bloodstream to maintain it within a therapeut= ic window. Read More](3D"https:/=) = 3D" Genetics & Stem Cells News [Gene Variation Causes Some Women to Store Fa= t, Increases Diabetes Risk](3D".=) [Here is one m= ore reason why some women have belly fat and heavy hips. A natural variatio= n of the gene KLF14 causes some women to store fat and this significantly i= ncreases their risk for type 2 diabetes. .](3D") [Read More](3D".=)= n> [=3D"Link](3D")= v> Mental Health News [Link Between Baby’s Brain Developmen= t and Sensory Experiences Identified](3D".=) [Mobility re= strictions or insufficient sensory stimuli influence the production of new = brain cells known as neurogenesis and impact brain growth. This may negativ= ely affect baby's learning and cognition..](3D") [Read More](3D".=)= pan> [3D"](3D") Hospital News [Two Times a Charm for Jerome Hamon- a Man = With a Second Face Transplant](3D".=) [After facing= complications with anti-rejection medications, Jerome Hamon’s previo= usly transplanted face tissue began to die, and so another transplant had t= o be done as the tissue death had left him with no skin at all..](3D") [Read More](3D".=)= an> [3D"Can](3D") Drug News [Can Cholesterol-lowerin= g Statins Ease Deadly Heart Condition in Rare Neuromuscular Disease?](3D".=)= 2> [In cell models that mimicked liver cells of patients with the rare = disease Friedreich's ataxia (FA), a widely used cholesterol-lowering drug w= as found to increase a precursor of HDL (high-density lipoprotein), the &ls= quo;good cholesterol,’ in preclinical studies..](3D") [Read More](3D".=) [3D"Ne=](3D") Genetics & Stem Cells News [New Genes That Underlie Human Pigmentation Identified](3D".=)= 2> [New study findings may pave w= ay for better understanding of conditions linked to pigmentation like vitil= igo and skin cancer..](3D") [Read More](3D".=) [3D"Ep=](3D") Research News [Epstein-Barr Viral Protein Increases Risk of Autoi= mmune Disease](3D".=) [Epstein-Barr virus = may trigger some cases of systemic lupus erythematosus and other chronic au= toimmune illnesses..](3D") [Read More](3D".=) [3D"Providing](3D") Research News [Providing Brain Organoids With the Support= ive Physiological Environment](3D".=) [Developing = more sophisticated organoid models by ensuring they receive sufficient oxyg= en and other nutrients via transplantation into rodents..](3D") [Read More](3D".=)= pan> [3D"New=](3D") AIDS/HIV News [New Mechanism shows How HIV evades Immune System](3D".=) [The mechanism of HIV invasion int= o the immune system has been identified. Also, HIV disables a pathway that = is the key to blocking viral activity..](3D") [Read More](3D".=) [3D"Culti=](3D") Genetics & Stem Cells News [Cultivating Cartilage from Human Stem Cells](3D".=) [Study opens new perspectives in the reg= eneration of articular cartilage and in the establishment of stem cell-base= d models of cartilage development..](3D") [Read More](3D".=) [3D"Gr=](3D") Research News [Growing Human Bone and Cartilage Tissues Using Nanopa= rticles](3D".=) [Study explores a new c= lass of clay nanoparticles that can direct stem cells to become bone or car= tilage cells..](3D") [Read More](3D".=) [View All News Stories on Medindia](3D") =20 [3D"medindia"](3D"=) =20 =20 - - 3D" - [3D""](3D") - [3D""](3D") - [3D""](3D") =20 =20 =20 Latest Healt= h News and What's New on Medindia =20 =20 =20 [[3D"Therapeutic] Article Therapeutic Dru= g Monitoring Therapeutic drug monitoring is measuring drug concentrations= at specific intervals in a patient's bloodstream to maintain it within a t= herapeutic window. Read More = er>](3D"=) =20 =20 =20 =20 =20 [3D"G=](3D") =20 =20 Genetics & Stem Cells News =20 [Gene Variation Causes Some Women to Store Fat, I= ncreases Diabetes Risk](3D"http=) [Here is one more = reason why some women have belly fat and heavy hips. A natural variation of= the gene KLF14 causes some women to store fat and this significantly incre= ases their risk for type 2 diabetes. .](3D") [Read More](3D".=) = =20 =20 3D" =20 =20 Mental Health News =20 [Link Between Baby=E2=80=99s Brain Development = and Sensory Experiences Identified](3D"http=) [Mobility restri= ctions or insufficient sensory stimuli influence the production of new brai= n cells known as neurogenesis and impact brain growth. This may negatively = affect baby's learning and cognition..](3D") [Read More](3D".=)= > =20 =20 3D" =20 =20 Hospital News =20 [Two Times a Charm for Jerome Hamon- a Man With= a Second Face Transplant](3D"http=) [After facing com= plications with anti-rejection medications, Jerome Hamon=E2=80=99s previous= ly transplanted face tissue began to die, and so another transplant had to = be done as the tissue death had left him with no skin at all..](3D") [Read More](3D".=)= =20 =20 [3D"Can](3D") =20 =20 Drug News =20 [Can Cholesterol-lowering St= atins Ease Deadly Heart Condition in Rare Neuromuscular Disease?](3D"http=) [In cell models that mimicked liver cells of patients with the rare dise= ase Friedreich's ataxia (FA), a widely used cholesterol-lowering drug was f= ound to increase a precursor of HDL (high-density lipoprotein), the = =E2=80=98good cholesterol,=E2=80=99 in preclinical studies..](3D") [= Read More](3D".=) =20 =20 [3D"New](3D") =20 =20 Genetics & Stem Cells News =20 [New Genes That Underlie Human Pigmentation Identified](3D"http=) [New study findings may pave way f= or better understanding of conditions linked to pigmentation like vitiligo = and skin cancer..](3D") [Read More](3D".=) =20 =20 [3D"Epstei=](3D") =20 =20 Research News =20 [Epstein-Barr Viral Protein Increases Risk of Autoimmun= e Disease](3D"http=) [Epstein-Barr virus may = trigger some cases of systemic lupus erythematosus and other chronic autoim= mune illnesses..](3D") [Read More](3D".=) = der> =20 =20 3D"= > =20 =20 Research News =20 [Providing Brain Organoids With the Supportive = Physiological Environment](3D"http=) [Developing more= sophisticated organoid models by ensuring they receive sufficient oxygen a= nd other nutrients via transplantation into rodents..](3D") [Read More](3D".=)= > =20 =20 [3D"New](3D") =20 =20 AIDS/HIV News =20 [New Mechanism shows How HIV evades Immune System](3D"http=) [The mechanism of HIV invasion into the= immune system has been identified. Also, HIV disables a pathway that is th= e key to blocking viral activity..](3D") [Read More](3D".=) =20 =20 [3D"Cultivating=](3D") =20 =20 Genetics & Stem Cells News =20 [Cultivating Cartilage from Human Stem Cells](3D"http=) [Study opens new perspectives in the regen= eration of articular cartilage and in the establishment of stem cell-based = models of cartilage development..](3D") [Read More](3D".=) =20 =20 [3D"Growing](3D") =20 =20 Research News =20 [Growing Human Bone and Cartilage Tissues Using Nanopartic= les](3D"http=) [Study explores a new class= of clay nanoparticles that can direct stem cells to become bone or cartila= ge cells..](3D") [Read More](3D".=) =20 [View All News Stories on Medindia](3D") =20 =0A [3D"visit](3D"=) [3D""] --b2_0aad299ca46bd71cf65620bd7ab8c87c Content-Type: image/png; name="powerphplist.png" Content-Transfer-Encoding: base64 Content-ID: Content-Disposition: inline; filename=powerphplist.png iVBORw0KGgoAAAANSUhEUgAAAEsAAAAhCAYAAACRIVbWAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz AAALEgAACxIB0t1+/AAAAB50RVh0U29mdHdhcmUAQWRvYmUgRmlyZXdvcmtzIENTNS4xqx9I6wAA DmhJREFUaIHtmntw1FWWxz+/Xz/T6aQTQgIkJgR5LGRIFDcPsSAEWEFkZSIisPIcRaTKEkEMwUGX RRaZWlSylKPrqBDFGCXyUAqiKLUg6ADBhCRAEGQhWU1IIpru9Lt/j/2jkx/ppEOwZmoetX6rurrv 45x77/fec+65t69AN4zOyMgDFgP5gK17+f8D2IG9QPGZmprDqqpqBULnj9EZGTFAMfDrv3Tv/obx EbC4trq6DTrI6iDqMHDbX69ff7OoBvJqq6vbxI6MYn4hqjfcRpAfhA4f9d9/zd78nWCiHljRW+nw zPGk507T0g11VZwqLwPAZLEybtbD2PoPxP7DVY59uA2f20lK2hgSBg/jVHkZtviBZE6bzaF3tgIw fdlv2f9fL/TQC3BoR7DO5AXLtbyuem9WpvaLci6eOtpjLLb4gSH1ju3aTkv9xaD8wuVaO+m50/C6 neF0rBCBvN7IssUHiTj1SRmnPiljRJcOT1/2WwBOfVIWkva6nKTn3gtcJ9tksZKSNgZb/MCwek99 Uoa99Sq2+EGYI61aHsC4WQ/ftEztF+VkTXuQ4Znjw4wltF5nfwFs/QeSPmGatgB8bmc4OvL09BEe 2FubaDhXFfydOw1TpBVb/EBs8YPY/XKwwYZzVfxm03Zs8QNpqb+IuaNOyqgxAIzIHE9U3ACunKlE kiQURUFVFGRZBqD+bCUAsizjcbbzPzUVAPRPvpUBqSN+lozBbCF55G3UHQ/1LLIso6rBb0WWMVms SJIEwJGdb/BgwX9gNEdy9fIFTZderw/hOyQVDuMeeJhxDzyskVJ7pJwBqcOxtzb1INUWPwh761Ua zlUxPHM8KWljOLZrGylpY4juP5CT+9/X6g/+1R3Y4geFDLwz/+nizzSdH/9+Q58y3fvxD1m5Ycts 8YPIvncOAD53O+ZIK16Xk+YrF7lQcYTs6XN4o2Bhr1z0SdaxXds0P9UJr8uJOdIaktfZMEBz/UWy ps2mpf4iDedOkzVtNiaLlfpz1wdYfXg/J/d/0KO9+rOVHCwuYsG/vUr14f00X7nYp0xIPyxWvOHN iOYrFyjbXAhA7oNLyMibrun7puKLjsluCisLIIbNVRRt6Ssdv7t+Gi/VYbJYSRs3FUmSSBs3FZPF SuOlOiRJ4nLtKUwWK+dPHqHxUh1eVzvNVy5qZPYFe2sTnxVvIffBJQxIHX5TMhCcsBHZE3pddV1h Sxh003o70efK6g0f/34DMx5/jimLV/Qwl+YrF7G3NlF/thK9KFJ75ECwMTE4N6IgMG7WI+Q+uEST 2V64mIDHhd/tRC+KXPr6GMc+fIs7p89l/2sbbyjT1XRPHdjJuS/KtbY60b1ew7kqznap17Xt3iCM zshQe+QqCpKi/CzyekM3J/l3jfAjEQSNYUEQkCQZj8eNXq8nOjqayMhIVFXF7XZjt9uRZRmLxYJO p6PrwfPPRfifikAggCAIf/LE9SIdHLAgCnjcHvz+AP+YeQdT7p7CqFGjSEhIQFVVWltbqamp4dCh Q5w+fRqj0YjZbA4hDIA+SFMUBa/XS4TZjHADM7gRZFnG5/NhiYgAQQjJH5SQgM/vp62tDZ1O16sO t9uN0WjEYDAEGeiiB3oxQ0FVAAG3243BYGDZsmXMnTuXAQMGhG2ksbGR0tJS3nzzTRRFwWQyoaoq kqIEZ/MGZCmKgsViITMzk4qKCrxeL0K3TvYFRVGIjY0lLS2NEydOIMsygiAQCARISUlh586dtLS0 MG/ePFwuV1jCVFVl7NixXLlyhe+//x6dXt+DrLDTqKgqfr8fm83GunXrePLJJ0OI8ng8vPLKKzz1 1FPU1dWRmJjIqlWreOaZZ1BVVVv2NwO/38+wYcN47bXXGDp0KD6f7+fwBIDX62Xs2LG8/vrrxMbG asGmqqrodDrMZjNms7nXPsmyTEREBC+99BL33HMPbrc7bL2wZujz+VBkBZPZRHZ2dkhZIBDgzbfe 4tzZs9xySzKbfvc7Nmx4nsEpg5k/fz6XL1/hjTf/QGxMLBD0eV6fD6VjdXVG4IIgYDQaARA7TE+S JJxOJ5IkIQgCJpMJg8GALMt4vV5EUeyIxIPG0ElEpz5ZlkP8ktFopL6+nqlTpxIIBHC5XEiShMfj 0eqIooher8fn8xEIBPB6vTidTqxRUT3IDUuWJEnceuutTJo4ibVr17Ju3TpGjhwJgMvlorLya+bO nsM/3X03CxYspKG+nsEpgxFFkYce+hcOHTrEd9//LyZzBH6/n7vuuouYmBgCgQD3338/UVFRVFdX U1payrfffhs0WUkiJyeHefPmkZSUREVFBSUlJbS2ttK/f39mzZrFhQsXmDx5Munp6TgcDvbs2cPn n38ePAqpqvbpCkVRmDFjBk1NTZSVlZGZmcns2bNJTU3l2rVrfPbZZxw/fpw1a9Zgs9mYP38+aWlp /PvGjfgDgRBdYc1QJ+rIysxi7dq1jL1rLAUFBZw/fx6AqKgoxt45lk8Pfsrb77zNwIEDGDp0mCY7 ZMgQcsePx+/zB1ei309+fj5FRUUUFRXh9Xqprq5m4sSJfPDBB4waNQqPx4MgCKxevZr4+Hhqamq4 7777eP/990lISCA+Pp7169dTWlpKXl4eNTU1eDwetm7dypo1awh0G1QnOonLz88nJyeHkSNHsn37 dpKSkqisrESWZZ5//nlycnI0nc3NzZw/f16zhD5XFoJAeno6AMufWI4syRQWFrJ582ZGjBjB0qWP MmPGr9lW/DZfHj1KYmLidYV6PWlpaRhNJk1Xpw8pKCjgww8/RBAEtm7dSklJCc899xxbtmxBp9Ox bds21q9fjyRJvPrqq+zdu5fly5dTXFwMwIkTJ3jkkUdoa2tDVVXmzJnDyy+/zL59+/B6vWGHAkEf 297eTnZ2NhEREaxYsYILFy5gtVoZNmwYLpcLh8PB4sWLOXjwIFu2bGFQYmKPnTn8Pq2qxMXFacmV K1eSl5dHYWEhly5dYs+evcTFxTHvoYd45513sNvtIeK2WBtGg0FLG41GGhoa+PTTT4mOjiYmJob2 9naKi4u5/fbbSU5ORpIkDh48iF6vp1+/fly7do0DBw5wxx13aH7pvffew+l0EhsbS0xMDAcOHOC7 775j0qRJmi/sDUajkZMnT+Lz+di5cyebNm1i4sSJNDc3Y7fbiY6ORhRFzGYzUWH8Va9kyYqCrIQ2 vnLlSqb/83SWPraU3Xt2s3btWl568UX8AT+rV6/G5XJpdRVZQeW67xBFkZ9++glJkjRnbjAY+PHH HxEEAavVqm33neV6vV5z9IIgoCgKbW1tmgPvdOjXrl2jX79+NyQKwGQyUVtby6JFi6ipqWHmzJmU lJSwY8cOEhMT8fv9feoIS5bRaKChvqFHflJiEs3NzbQ72omNjcVsNrPh+Q1YrVaeLnha2/abmq/i 811vXJZlEhMTsVgsmn/xer0MHz4cv99Pa2srer2+x2wKgqD5HVEUSU1N1cwtEAgQGRlJamoqly9f 7nOgnTpOnjzJihUrmDp1KgsWLCA9PZ2FCxdqZPUIqPsiy2QyceLEiZC8uro6it9+m9LS98nLy2Pj xo2oqorVamXjxo1YIiyseWYNDoeDs2fOIklBUgSCoUh8fDyrVq3CaDTidDrJysriiSeeYN++fTQ3 N6PT6cKS1UmYLMs8/vjjZGdn43Q6MRgMFBQUEBERQXl5OaYOH+nz+fB6vfh8Pi0cEAQBn8/HvHnz KCwsJDo6GrvdTlVVFQ6HQzu+GQwGRFHE6/WGJa2X445AZWUlx48f58477wSCUTqqyoCEBIaPGE5V VRV+vx+TyYTZbOaFF15g06ZNLF36GN83fkdkx32XSjAeamtr495772XKlCk4HA6SkpL46quv2Lx5 M2lpaQAhfkdVVQRBwGAwQEeQ7PV62bFjB42NjVitVgwGAytXruTy5ctkZWVhMBgoKSnB7/drxO/a tUtLe71eFi1axMyZM3E4HMTExOByuXj33Xfx+XwcPXqUpUuXkpmZyaqnn8bXzTSF0RkZbXS7WhZQ cTpdZGdl8oc33iA6Khq3282zzz5Lyw+tSIEAc+fMJT8/P0RZa2sr+fn5NDY1ER0djT8QwO/3859b tpCcnMzSRx8ld8IEoqxWvvnmGyoqKpAVhZiYGLKzszl+/DgejwexYwdNHTKEuLg4PB4Pu3fvZsmS JTgcDtLT03E6nXx57BiNTU2YTCZibDZyJ0wgMjIyZIWePXMGCO6I1TU1DE5JITMri9jYWFpaWvjj V3+kzR70hWazmcmTJ2PQ6zlQXg6hu6FdGJ2RsZdu/0ILqMiqgqPNzv33z2Tdv64jLq4fHo+H/Qf2 k3xLMjk5OSFE/fDDD2x+8UX27fsYnU6PIEBAkvH7/WwtKmLw4MEs+s1iTOYIVEVBbzBgMpkQRQFF VvB4PERYIhAFsbMTBAIS9rY2hgwZwq6yMh5btoyvq6ow6PUIooDJZMag14MQXJVutxu6WY/RaERV VURRxGgyEggE8Pv8KIqCqBMxmczodboOHQoetxsEgcjISK42hdyafqQHirqTBQI6UUd0VDS7d++m taWVJUseYfLkycx6YFZITVmWOXzkCNu3b+PYsS+DMysK0GHzqqqi1+vR6XToDUYyszK1sj4hCJw+ Xa0lVYJBcTAGVK9n/rxz902jG1lFnX/fh6wuQSA4IEFEUSTaHU5stmgybruN9F+N5pbkZFRVpamx kZqaGmrPnsHe1kZkpBVRJ3aQIRCQJFRVJXPMGMwREXxx9GjwxH+ztwoqqKpCtM3GpEmTOHz4MD/9 +CPiDa5Z/pzocs78qLa6Oj/sWwdR0PraQVxwl5EkCQQw6A0gCMiShKIqGPQG7VDcFf6AhMFgwOvx BK9iOnadnwtFUXB7PFgiIrQ47C8I7a3DL69oboyer2i64pf3Wb2/z/o/Z4jQ19LLyeMAAAAASUVO RK5CYII= --b2_0aad299ca46bd71cf65620bd7ab8c87c--

Marketing emails from medindia.net

View More
Sent On

27/12/2018

Sent On

23/12/2018

Sent On

16/12/2018

Sent On

12/10/2018

Sent On

11/10/2018

Sent On

07/10/2018

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.